Titan Pharmaceuticals Statistics

Total Valuation

TTNP has a market cap or net worth of $6.37 million. The enterprise value is -$835,789.

Market Cap	6.37M
Enterprise Value	-835,789

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

TTNP has 914,234 shares outstanding. The number of shares has increased by 11.90% in one year.

Shares Outstanding	914,234
Shares Change (YoY)	+11.90%
Shares Change (QoQ)	+0.64%
Owned by Insiders (%)	45.47%
Owned by Institutions (%)	5.52%
Float	699,983

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	34.63
Forward PS	n/a
PB Ratio	0.96
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.55, with a Debt / Equity ratio of 0.09.

Current Ratio	5.55
Quick Ratio	5.41
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -165.90% and return on invested capital (ROIC) is -100.97%.

Return on Equity (ROE)	-165.90%
Return on Assets (ROA)	-105.70%
Return on Capital (ROIC)	-100.97%
Revenue Per Employee	$46,000
Profits Per Employee	-$1.39M
Employee Count	4
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.32% in the last 52 weeks. The beta is 1.35, so TTNP's price volatility has been higher than the market average.

Beta (1Y)	1.35
52-Week Price Change	-55.32%
50-Day Moving Average	7.32
200-Day Moving Average	8.15
Relative Strength Index (RSI)	46.36
Average Volume (30 Days)	10,859

Short Selling Information

The latest short interest is 10,179, so 1.11% of the outstanding shares have been sold short.

Short Interest	10,179
Short Previous Month	3,914
Short % of Shares Out	1.11%
Short % of Float	1.45%
Short Ratio (days to cover)	0.33

Income Statement

In the last 12 months, TTNP had revenue of $184,000 and -$5.57 million in losses. Loss per share was -$7.41.

Revenue	184,000
Gross Profit	184,000
Operating Income	-7.28M
Pretax Income	-5.57M
Net Income	-5.57M
EBITDA	-5.46M
EBIT	-5.57M
Loss Per Share	-$7.41

Full Income Statement

Balance Sheet

The company has $7.77 million in cash and $565,000 in debt, giving a net cash position of $7.21 million or $7.88 per share.

Cash & Cash Equivalents	7.77M
Total Debt	565,000
Net Cash	7.21M
Net Cash Per Share	$7.88
Equity / Book Value	6.64M
Book Value Per Share	7.27
Working Capital	6.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.09 million and capital expenditures -$2,000, giving a free cash flow of -$7.09 million.

Operating Cash Flow	-7.09M
Capital Expenditures	-2,000
Free Cash Flow	-7.09M
FCF Per Share	-$9.43

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -3,954.89% and -3,026.63%.

Gross Margin	100.00%
Operating Margin	-3,954.89%
Pretax Margin	-3,026.63%
Profit Margin	-3,026.63%
EBITDA Margin	-2,965.76%
EBIT Margin	-3,026.63%
FCF Margin	-3,855.43%

Dividends & Yields

TTNP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-11.90%
Shareholder Yield	-11.90%
Earnings Yield	-87.40%
FCF Yield	-111.33%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 9, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 9, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

TTNP has an Altman Z-Score of -66.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-66.47
Piotroski F-Score	1